Luye offers sweetest pill with $764m IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Luye offers sweetest pill with $764m IPO


Luye Pharma Group has priced its HK$5.9bn ($764m) IPO at the top of the range, as the healthcare sector found favour among investors. But heavily subscribed books meant that some accounts ended up empty handed.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article